Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions.

IF 2.3 4区 医学 Q3 ONCOLOGY
Reza Vazifehmand, Dhuha Saeed Ali, Foroozandeh Monem Homaie, Fatemeh Molaei Jalalvand, Zulkefley Othman, Chau Deming, Johnson Stanslas, Zamberi Sekawi
{"title":"Effects of HSV-G47Δ Oncolytic Virus on Telomerase and Telomere Length Alterations in Glioblastoma Multiforme Cancer Stem Cells Under Hypoxia and Normoxia Conditions.","authors":"Reza Vazifehmand, Dhuha Saeed Ali, Foroozandeh Monem Homaie, Fatemeh Molaei Jalalvand, Zulkefley Othman, Chau Deming, Johnson Stanslas, Zamberi Sekawi","doi":"10.2174/0115680096274769240115165344","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Due to the existence of tumor stem cells with tumorigenicity properties and resistance patterns, treatment of glioblastoma is not easy. Hypoxia is a major concern in glioblastoma therapy. Telomerase activity and telomere length alterations have been known to play a critical role in glioblastoma progression and invasion.</p><p><strong>Objective: </strong>This study aimed to investigate the effects of HSV-G47Δ oncolytic virus on telomerase and telomere length alterations in U251GBMCSCs (U251-Glioblastoma cancer stem cells) under hypoxia and normoxia conditions.</p><p><strong>Methods: </strong>U251-CSCs were exposed to the HSV-G47Δ virus in optimized MOI (Multiplicity of infection= 1/14 hours). An absolute telomere length and gene expression of telomerase subunits were determined using an absolute human telomere length quantification PCR assay. Furthermore, a bioinformatics pathway analysis was carried out to evaluate physical and genetic interactions between dysregulated genes with other potential genes and pathways.</p><p><strong>Results: </strong>Data revealed that U251CSCs had longer telomeres when exposed to HSV-G47Δ in normoxic conditions but had significantly shorter telomeres in hypoxic conditions. Furthermore, <i>hTERC, DKC1</i>, and <i>TEP1</i> genes were significantly dysregulated in hypoxic and normoxic microenvironments. The analysis revealed that the expression of TERF2 was significantly reduced in both microenvironments, and two critical genes from the MRN complex, MER11 and RAD50, were significantly upregulated in normoxic conditions. RAD50 showed a significant downregulation pattern in the hypoxic niche. Our results suggested that repair complex in the telomeric structure could be targeted by HSV-G47Δ in both microenvironments.</p><p><strong>Conclusion: </strong>In the glioblastoma treatment strategy, telomerase and telomere complex could be potential targets for HSV-G47Δ in both microenvironments.</p>","PeriodicalId":10816,"journal":{"name":"Current cancer drug targets","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current cancer drug targets","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0115680096274769240115165344","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Due to the existence of tumor stem cells with tumorigenicity properties and resistance patterns, treatment of glioblastoma is not easy. Hypoxia is a major concern in glioblastoma therapy. Telomerase activity and telomere length alterations have been known to play a critical role in glioblastoma progression and invasion.

Objective: This study aimed to investigate the effects of HSV-G47Δ oncolytic virus on telomerase and telomere length alterations in U251GBMCSCs (U251-Glioblastoma cancer stem cells) under hypoxia and normoxia conditions.

Methods: U251-CSCs were exposed to the HSV-G47Δ virus in optimized MOI (Multiplicity of infection= 1/14 hours). An absolute telomere length and gene expression of telomerase subunits were determined using an absolute human telomere length quantification PCR assay. Furthermore, a bioinformatics pathway analysis was carried out to evaluate physical and genetic interactions between dysregulated genes with other potential genes and pathways.

Results: Data revealed that U251CSCs had longer telomeres when exposed to HSV-G47Δ in normoxic conditions but had significantly shorter telomeres in hypoxic conditions. Furthermore, hTERC, DKC1, and TEP1 genes were significantly dysregulated in hypoxic and normoxic microenvironments. The analysis revealed that the expression of TERF2 was significantly reduced in both microenvironments, and two critical genes from the MRN complex, MER11 and RAD50, were significantly upregulated in normoxic conditions. RAD50 showed a significant downregulation pattern in the hypoxic niche. Our results suggested that repair complex in the telomeric structure could be targeted by HSV-G47Δ in both microenvironments.

Conclusion: In the glioblastoma treatment strategy, telomerase and telomere complex could be potential targets for HSV-G47Δ in both microenvironments.

HSV-G47Δ 肿瘤溶解病毒对缺氧和正常缺氧条件下多形胶质母细胞瘤癌干细胞端粒酶和端粒长度变化的影响
背景:由于肿瘤干细胞具有致瘤特性和抗药性,胶质母细胞瘤的治疗并非易事。缺氧是胶质母细胞瘤治疗中的一个主要问题。已知端粒酶活性和端粒长度改变在胶质母细胞瘤的进展和侵袭中起着关键作用:本研究旨在探讨 HSV-G47Δ 溶瘤病毒在缺氧和常氧条件下对 U251GBMCSCs(U251-胶质母细胞瘤癌干细胞)端粒酶和端粒长度改变的影响:方法:将 U251-CSCs 暴露于优化 MOI(感染倍率=1/14 小时)的 HSV-G47Δ 病毒。采用人类端粒绝对长度定量 PCR 法测定端粒绝对长度和端粒酶亚基的基因表达。此外,还进行了生物信息学通路分析,以评估失调基因与其他潜在基因和通路之间的物理和遗传相互作用:结果:数据显示,U251CSCs在常氧条件下暴露于HSV-G47Δ时端粒较长,但在缺氧条件下端粒明显缩短。此外,hTERC、DKC1和TEP1基因在缺氧和正常缺氧微环境中都出现了明显的失调。分析表明,TERF2 在两种微环境中的表达都明显减少,而 MRN 复合物中的两个关键基因 MER11 和 RAD50 在常氧条件下明显上调。RAD50在低氧龛中则出现了明显的下调模式。我们的研究结果表明,在这两种微环境中,端粒结构中的修复复合物都可能成为HSV-G47Δ的靶点:结论:在胶质母细胞瘤的治疗策略中,端粒酶和端粒复合体可能是HSV-G47Δ在两种微环境中的潜在靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Current cancer drug targets
Current cancer drug targets 医学-肿瘤学
CiteScore
5.40
自引率
0.00%
发文量
105
审稿时长
1 months
期刊介绍: Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes and genes. Current Cancer Drug Targets publishes original research articles, letters, reviews / mini-reviews, drug clinical trial studies and guest edited thematic issues written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信